Conclusion
weight loss
In this trial testing probiotics for weight loss, no effect was observed after the double-blinded 3-month phase. For those who received double dose for 3 months who continued with triple dose for another 3 months in the open study phase, a modest but significant weight loss of approximately 2 kg or 0.7 BMI units was observed. A reduction in blood pressure was also noted. The current study provides evidence that a double and triple dose of the probiotic compound AB001 is well tolerated and can be consumed safely by adults. Further studies are required to certify to which extent this compound can facilitate weight loss and metabolic benefits.